Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Man who attempted to assassinate Kavanaugh now identifies as a woman

by admin September 20, 2025
September 20, 2025
Man who attempted to assassinate Kavanaugh now identifies as a woman

A man who pleaded guilty to attempting to kill Supreme Court Justice Brett Kavanaugh in 2022 is now using a female name and pronouns, according to a court document filed Friday. 

Nicholas Roske, who is scheduled to be sentenced next month, is using the name Sophie Roske and a ‘Ms.’ title for the first time in a court filing in a case that has stretched for three years.

The court filing was a routine request in anticipation of Roske’s sentencing, which is set for Oct. 3. But the filing referenced Roske by the name ‘Sophia,’ while a footnote revealed that Nicholas remains Roske’s legal first name.

‘Out of respect for Ms. Roske, the balance of this pleading and counsel’s in-court argument will refer to her as Sophie and use female pronouns,’ the footnote stated.

It is unclear if Roske is undergoing any treatments to become transgender. Fox News Digital reached out to the defendant’s defense team for comment.

Roske arrived at Kavanaugh’s house June 8, 2022, with a pistol, ammunition, a knife, a crowbar and tactical gear. Roske eventually called 9-1-1 and turned himself in after receiving a call from his sister and observing U.S. marshals in front of the justice’s house.

The incident occurred just two weeks before the Supreme Court handed down its landmark decision overturning Roe v. Wade, an expected decision that had drawn protesters to the Supreme Court building and conservative justices’ houses for weeks leading up to it.

The Department of Justice is seeking a 30-year sentence. In a sentencing memorandum, prosecutors referenced ‘mental health issues’ the defendant has had for about a decade that included thoughts of violently murdering his sister. He has received treatment for the issues, specifics of which were not included in the memorandum.

‘While the defendant has mental health issues, those issues do not detract from the gravity of the defendant’s crime: the defendant researched and targeted multiple members of the judiciary, and intended to alter the composition of the Supreme Court for ideological reasons,’ prosecutors wrote.

The revelation of the gender label switch comes as the DOJ has internally discussed concerns with transgender people owning guns and as conservative activist Charlie Kirk’s alleged assassin, Tyler Robinson, was discovered to have been in a romantic relationship with a transgender person. While the investigation remains open and authorities are still developing an understanding of the motive, authorities have said Robinson felt Kirk spread hate, which drove him to carry out the killing.

A Bureau of Prisons spokesperson said in a statement to Fox News the bureau could not confirm details about any gender-related treatments Roske may have received.

‘For privacy, safety and security reasons, the Bureau of Prisons (BOP) does not comment on the conditions of confinement for any incarcerated individual, including health information status or treatments,’ the spokesperson said.

This post appeared first on FOX NEWS

previous post
Copper Quest Closes Second and Final Tranche of Financing
next post
Charlie Kirk credited with helping Trump gain significant ground with young voters

Related Posts

Federal judge orders Trump admin to restore public...

February 12, 2025

Elon Musk tapped to help lead investigation into...

March 27, 2025

Trump says ‘I can’t believe I said that’...

February 28, 2025

Rand Paul says he would support ‘big, beautiful...

June 2, 2025

Bush teams up with notorious Trump foes to...

July 3, 2025

‘Designated terrorists’: Extremist groups raked in millions from...

February 11, 2025

Rubio pauses foreign aid from State Department and...

January 27, 2025

Trump, Putin on same page about Iran’s nuclear...

March 19, 2025

Trump and Zelenskyy war of words heats up...

February 20, 2025

Senate committee advances nomination of Dr Oz to...

March 26, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved